Edition:
United States

Akers Biosciences Inc (AKER.OQ)

AKER.OQ on NASDAQ Stock Exchange Capital Market

0.48USD
12:01pm EDT
Change (% chg)

$-0.03 (-5.34%)
Prev Close
$0.51
Open
$0.51
Day's High
$0.51
Day's Low
$0.47
Volume
643,829
Avg. Vol
2,702,969
52-wk High
$1.82
52-wk Low
$0.12

Chart for

About

Akers Biosciences, Inc. develops, manufactures and supplies point-of-care screening and testing products designed to bring health-related information to the patient or clinician. The Company's product offerings and pipeline products focus on delivering diagnostic assistance in a range of healthcare fields/specialties, including... (more)

Overall

Beta: -0.92
Market Cap(Mil.): $46.65
Shares Outstanding(Mil.): 86.94
Dividend: --
Yield (%): --

Financials

  AKER.OQ Industry Sector
P/E (TTM): -- 178.44 32.31
EPS (TTM): -0.57 -- --
ROI: -92.87 -0.73 12.97
ROE: -108.04 -2.77 14.84

BRIEF-Akers Biosciences Expands Outsourced U.S. Distribution Capabilities For Heparin PF4 Rapid Test

* AKERS BIOSCIENCES EXPANDS OUTSOURCED US DISTRIBUTION CAPABILITIES FOR HEPARIN PF4 RAPID TEST

Apr 12 2018

BRIEF-Akers Biosciences Reports Earnings For Fiscal Year 2017

* AKERS BIOSCIENCES REPORTS EARNINGS FOR FISCAL YEAR 2017 Source text for Eikon: Further company coverage:

Apr 03 2018

BRIEF-Akers Biosciences Signs Distribution Agreement With Diagnostica Stago

* AKERS BIOSCIENCES SIGNS US DISTRIBUTION AGREEMENT WITH DIAGNOSTICA STAGO

Mar 26 2018

BRIEF-Akers Biosciences Announces Distribution Agreement With Diagnostica Stago​

* ‍ENTERED INTO 3-YEAR DISTRIBUTION AGREEMENT WITH DIAGNOSTICA STAGO FOR SALE OF CO'S RAPID TEST FOR HEPARIN-INDUCED THROMBOCYTOPENIA ACROSS US​ Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

Mar 26 2018

BRIEF-Alpha Capital Anstalt Reports 9.9 Pct Passive Stake In Akers Biosciences

* ALPHA CAPITAL ANSTALT REPORTS 9.9 PERCENT PASSIVE STAKE IN AKERS BIOSCIENCES INC AS ON DECEMBER 21 - SEC FILING Source text (http://bit.ly/2BZ9Q04) Further company coverage:

Dec 22 2017

BRIEF-Akers Biosciences - Accutest Solutions secured new channel partner for sales​

* Akers Biosciences - ‍announces Accutest Solutions a distributor of Akers Bio's breathscan alcohol detector in UK, secured new channel partner for sales​

Nov 14 2017

Earnings vs. Estimates